Showing results 1 to 20 of 25
next >
Issue Date | Title | Author(s) |
2017 | Abstract P1-04-09: The missing link: Chemicals, epigenetics and breast cancer | Maund, PR; Ermler, S; Widschwendter, M; Silva, E |
2016 | Abstract P6-05-03: Investigating the effects of low-dose mixtures of environmental contaminants on breast cancer initiation | Silva, E; Ermler, S; Widschwendter, M; Maund, PR |
2007 | Activity of xenoestrogens at nanomolar concentrations in the E-screen assay | Silva, E; Scholze, M; Kortenkamp, A |
2021 | Characterisation of ACBD3 and PI4Kβ expression in breast cancer and the effects of ACBD3 overexpression | Houghton-Gisby, Jack |
19-May-2015 | Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms | Gérard, C; Mestdagt, M; Tskitishvili, E; Communal, L; Gompel, A; Silva, E; Arnal, JF; Lenfant, F; Noel, A; Foidart, JM; Péqueux, C |
2002 | Combining xenoestrogens at levels below individual No-observed-effect concentrations dramatically enhances steroid hormone action | Rajapakse, N; Silva, E; Kortenkamp, A |
2020 | Conceptual design and development of a research tool: - the Vagina-on-chip (VOC) | Naveenathayalan, Angel Kayalvilli |
2012 | Disruption of 3D MCF-12A breast cell cultures by estrogens - An in vitro model for ER-mediated changes indicative of hormonal carcinogenesis | Marchese, S; Silva, E |
2008 | Estrogens and genomic instability in human cancer cells-involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals | Kabil, A; Silva, E; Kortenkamp, A |
2014 | Extending the applicability of the dose addition model to the assessment of chemical mixtures of partial agonists by using a novel toxic unit extrapolation method | Scholze, M; Silva, E; Kortenkamp, A |
25-Jun-2024 | Fibroblastic tissue growth on polymeric electrospun membranes: a feasibility study | Osório, LA; Naveenathayalan, A; Silva, E; Mackay, RE |
9-Nov-2016 | Functional and prognostic significance of the genomic amplification of frizzled receptor 6 ( FZD6 ) in breast cancer | Corda, G; Sala, G; Lattanzio, R; Iezzi, M; Sallese, M; Fragassi, G; Lamolinara, A; Mirza, H; Barcaroli, D; Ermler, S; Silva, E; Yasaei, H; Newbold, RF; Vagnarelli, P; Mottolese, M; Natali, PG; Perracchio, L; Quist, J; Grigoriadis, A; Marra, P; Tutt, AN; Piantelli, M; Iacobelli, S; De Laurenzi, V; Sala, A |
2024 | The identification and evaluation of novel biomarkers for epithelial ovarian cancer | Filipe, Alice Madeira Williams |
5-May-2021 | Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer | Zahra, A; Dong, Q; Hall, M; Jeyaneethi, J; Silva, E; Karteris, E; Sisu, C |
2022 | Identification of potential Bisphenol A (BPA) exposure biomarkers in ovarian cancer and to predict the consequences of SNPs on biomarkers of ovarian cancer | Zahra, Aeman |
2018 | Investigating the effects of bisphenol a on the human placenta | de Aguiar Greca, Sophie-Christine |
3-Feb-2020 | Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation | de Aguiar Greca, S-C; Kyrou, I; Pink, R; Randeva, H; Grammatopoulos, D; Silva, E; Karteris, E |
14-Oct-2020 | Is there a link between bisphenol A (BPA), a key endocrine disruptor, and the risk for SARS-CoV-2 infection and severe COVID-19? | Zahra, A; Sisu, C; Silva, E; De Aguiar Greca, S-C; Randeva, H; Chatha, K; Kyrou, I; Karteris, E |
1-Nov-2022 | Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy | Gomes, S; Baltazar, F; Silva, E; Preto, A |
2018 | The missing link: endocrine disrupting chemicals, epigenetics and breast cancer risk | Maund, Phoebe Rebekah |